- Home
- TENX vs NAII Comparison
TENX vs NAII Comparison
Compare TENX & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- NAII
- Stock Information
- Founded
- TENX 1967
- NAII 1980
- Country
- TENX United States
- NAII United States
- Employees
- TENX N/A
- NAII N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- NAII Medicinal Chemicals and Botanical Products
- Sector
- TENX Health Care
- NAII Health Care
- Exchange
- TENX Nasdaq
- NAII Nasdaq
- Market Cap
- TENX 21.6M
- NAII 18.6M
- IPO Year
- TENX N/A
- NAII 1987
- Fundamental
- Price
- TENX $5.82
- NAII $3.17
- Analyst Decision
- TENX Strong Buy
- NAII
- Analyst Count
- TENX 3
- NAII 0
- Target Price
- TENX $16.00
- NAII N/A
- AVG Volume (30 Days)
- TENX 13.0K
- NAII 24.0K
- Earning Date
- TENX 05-20-2025
- NAII 05-13-2025
- Dividend Yield
- TENX N/A
- NAII N/A
- EPS Growth
- TENX N/A
- NAII N/A
- EPS
- TENX N/A
- NAII N/A
- Revenue
- TENX N/A
- NAII $121,853,000.00
- Revenue This Year
- TENX N/A
- NAII N/A
- Revenue Next Year
- TENX N/A
- NAII N/A
- P/E Ratio
- TENX N/A
- NAII N/A
- Revenue Growth
- TENX N/A
- NAII N/A
- 52 Week Low
- TENX $2.77
- NAII $2.57
- 52 Week High
- TENX $7.89
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- TENX 52.41
- NAII 54.18
- Support Level
- TENX $5.34
- NAII $2.69
- Resistance Level
- TENX $5.87
- NAII $3.37
- Average True Range (ATR)
- TENX 0.34
- NAII 0.32
- MACD
- TENX 0.04
- NAII 0.04
- Stochastic Oscillator
- TENX 86.99
- NAII 68.18
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.